The roles of striatal serotonin and l-amino-acid decarboxylase on l-DOPA-induced dyskinesia in a hemiparkinsonian rat model

Cellular and Molecular Neurobiology

Volumn 30, Issue 6, 2010, Pages 817-825

  Gil, Sukju ^a   Park, Changhwan ^a   Lee, Jeongeun ^a   Koh, Hyunchul ^a  

^a Hanyang University   (South Korea)

Author keywords

Dopamine; Dyskinesia; L Amino acid decarboxylase; L DOPA; Serotonin

Indexed keywords

AMINO ACID DECARBOXYLASE; BENSERAZIDE; DOPAMINE; LEVODOPA; OXIDOPAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOPAMINE RELEASE; DYSKINESIA; FEMALE; IMMUNOREACTIVITY; MOTOR CONTROL; MOTOR PERFORMANCE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAPHE NUCLEUS; RAT; STRIATE CORTEX;

ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; FEMALE; LEVODOPA; MOVEMENT; NEOSTRIATUM; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 77956184905     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-010-9509-9     Document Type: Article

References (44)

1. JE Ahlskog MD Muenter 2001 Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 448 458 10.1002/mds.1090 1:STN:280:DC%2BD3MzitVCmtg%3D%3D 11391738
2. 1 agonist SKF 82958 Behav Pharmacol 10 175 182 10.1097/00008877-199903000-00006 1:CAS:528: DyaK1MXktlCjurw%3D 10780830
3. AH Anton DF Sayre 1962 A study of the factors affecting the aluminum oxide-trihydroxyindole procedures for the analysis of catecholamine J Pharamcol Exp Ther 138 360 375 1:CAS:528:DyaF3sXlsVOnsg%3D%3D
4. R Arai N Karasawa M Geffard T Nagatsu I Nagatsu 1994 Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase Brain Res 667 295 299 10.1016/0006-8993(94)91511-3 1:CAS:528:DyaK2MXjtVSntrc%3D 7697371
5. R Arai N Karasawa M Geffard I Nagatsu 1995 L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study Neurosci Lett 195 195 198 10.1016/0304-3940(95)11817-G 1:CAS:528:DyaK2MXns1Giur8%3D 8584208
6. R Arai N Karasawa I Nagatsu 1996 Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study Brain Res 706 177 179 10.1016/0006-8993(95)01281-8 1:CAS:528:DyaK28XkslKmug%3D%3D 8720509
7. 1 dopamine receptor signaling in levodopa-induced dyskinesia Ann Neurol 57 17 26 10.1002/ana.20296 1:CAS:528:DC%2BD2MXpsFSksw%3D%3D 15514976
8. 1A agonist in advanced Parkinson's disease Mov Disord 20 932 936 10.1002/mds.20370 15791634
9. W Bara-Jimenez TD Dimitrova A Sherzai M Aksu TN Chase 2006 Glutamate release inhibition ineffective in levodopa-induced motor complications Mov Disord 21 1380 1383 10.1002/mds.20976 16758479
10. JD Berke RF Paletzki GJ Aronson SE Hyman CR Gerfen 1998 A complex program of striatal gene expression induced by dopaminergic stimulation J Neurosci 18 5301 5310 1:CAS:528:DyaK1cXksFartrg%3D 9651213
11. 1A agonist improves motor complications in rodent and primate parkinsonian models Neurology 57 1829 1834 1:CAS:528:DC%2BD38XjvVI%3D 11723272
12. 2 receptor mediated mechanisms using dopaminergic agonists in MPTP monkeys J Neural Transm 45 103 112 1:CAS:528:DyaK28Xhtlyks7g%3D
13. S Boyce NM Rupniak MJ Steventon SD Iversen 1990 Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys Clin Neuropharmacol 13 448 458 10.1097/00002826-199010000-00006 1:STN:280: DyaK3M7gsFOnuw%3D%3D 2272024
14. 2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding Pharmacol Exp Ther 240 167 176 1:CAS:528:DyaL2sXhtlWls74%3D
15. JM Brotchie J Lee K Venderova 2005 Levodopa-induced dyskinesia in Parkinson's disease J Neural Transm 112 359 391 10.1007/s00702-004-0251-7 1:CAS:528:DC%2BD2MXhsVOmtrk%3D 15614429
16. A receptors in the striatopallidal complex Brain Res 680 43 52 10.1016/0006-8993(95)00229-J 1:CAS:528:DyaK2MXmtVynsbY%3D 7663983
17. T Carlsson M Carta C Winkler A Björklund D Kirik 2007 Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease J Neurosci 27 8011 8022 10.1523/JNEUROSCI.2079-07.2007 1:CAS:528:DC%2BD2sXoslSjsb0%3D 17652591
18. M Carta HS Lindgren M Lundblad R Stancampiano F Fadda MA Cenci 2006 Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats J Neurochem 96 1718 1727 10.1111/j.1471-4159.2006.03696.x 1:CAS:528:DC%2BD28Xjs1Orsbk%3D 16539687
19. M Carta T Carlsson D Kirik A Bjorklund 2007 Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 130 1819 1833 10.1093/brain/awm082 17452372
20. MA Cenci 2007 Dopamine dysregulation of movement control in L-DOPA-induced dyskinesis Trends Neurosci 30 236 243 10.1016/j.tins.2007.03.005 1:CAS:528:DC%2BD2sXkslent7s%3D 17400300
21. MA Cenci CS Lee A Björklund 1998 L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur J Neurosci 10 2694 2706 10.1046/j.1460-9568.1998. 00285.x 1:STN:280:DyaK1M7ksFKrsA%3D%3D 9767399
22. R de la Fuente-Fernandez M Schulzer E Mak DB Calne AJ Stoessl 2004 Presynaptic mechanisms of motor fluctuations in Parkinson's disease; a probabilistic model Brain 127 888 899 10.1093/brain/awh102
23. A Dekundy M Lundblad W Danysz MA Cenci 2007 Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds; further validation of the dyskinesia model Behav Brain Res 179 76 89 10.1016/j.bbr.2007.01.013 1:CAS:528:DC%2BD2sXjsVegur8%3D 17306893
24. 1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat Brain Res 1158 135 143 10.1016/j.brainres.2007.05.005 1:CAS:528:DC%2BD2sXotVWltrk%3D 17553470
25. 1A agonist buspirone reduces the expression and development of L-DOPA-induced dyskinesia in rats and improves L-DOPA efficacy Pharmacol Biochem Behav 87 306 314 10.1016/j.pbb.2007.05.002 1:CAS:528:DC%2BD2sXotlWlt74%3D 17553556
26. MJ Guerra I Liste JL Labanderia-Garcia 1997 Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats Neuroreport 8 3485 3488 10.1097/00001756-199711100-00014 1:CAS:528:DyaK2sXnsVyqtLg%3D 9427312
27. MK Home CH Cheng GF Woodten 1984 The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study Pharmacology 28 12 26 10.1159/000137938
28. MJ Hurley P Jenner 2006 What has been learnt from study of dopamine receptors in Parkinson's disease? Pharmacol Ther 111 715 728 10.1016/j.pharmthera.2005.12.001 1:CAS:528:DC%2BD28Xns1Sks7s%3D 16458973
29. 1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation J Neurochem 76 1346 1353 10.1046/j.1471-4159.2001.00184.x 1:CAS:528:DC%2BD3MXhvVCjtb4%3D 11238719
30. E Lane S Dunnett 2008 Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic? Psychopharmacology 199 303 312 10.1007/s00213-007-0931-8 1:CAS:528:DC%2BD1cXotVyrsLg%3D 17899020
31. CS Lee MA Cenci M Schulzer A Björklund 2000 Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease Brain 123 1365 1379 10.1093/brain/123.7.1365 10869049
32. M Lundblad M Andersson C Winkler D Kirik N Wierup MA Cenci 2002 Pharmacological validation of behavioral measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur J Neurosci 15 120 132 10.1046/j.0953-816x.2001.01843.x 1:STN:280:DC%2BD387ktFynug%3D%3D 11860512
33. T Maeda K Kannari H Shen A Arai M Tomiyama M Matsunaga T Suda 2003 Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation Neurosci Lett 343 17 20 10.1016/S0304- 3940(03)00295-7 1:CAS:528:DC%2BD3sXjs1Crsr4%3D 12749987
34. R Miller RJ Beninger 1991 On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animal with unilateral depletion of striatal dopamine Prog Neurobiol 36 229 256 10.1016/0301-0082(91) 90032-V 1:CAS:528:DyaK3MXlt1Oitrk%3D 1673254
35. JW Mink 1996 The basal ganglia; focused selection and inhibition of competing motor programs Prog Neurobiol 50 381 425 10.1016/S0301-0082(96)00042-1 1:STN:280:DyaK2s7lvVSksA%3D%3D 9004351
36. L-DOPA- induced dyskinesia Brain 131 3380 3394 10.1093/brain/awn235 18952677
37. KY Ng TN Chase RW Colburn IJ Kopin 1970 L-Dopa-induced release of cerebral monoamines Science 170 76 77 10.1126/science.170.3953.76 1:CAS:528:DyaE3cXltFyrs7Y%3D 5452893
38. AP Nicholas K Buck B Ferger 2008 Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity Neurosci Lett 443 204 208 10.1016/j.neulet.2008.07.039 1:CAS:528:DC%2BD1cXhtVKmur7F 18657593
39. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
40. F Stocchi G Nordera CD Marsden 1997 Strategies for treating patient with advanced Parkinson's disease with disastrous fluctuation and dyskinesias Clin Neuropharmacol 20 95 115 10.1097/00002826-199704000-00001 1:STN:280: DyaK2s3lsVahtQ%3D%3D 9099462
41. Y Takeuchi T Sawada S Blunt P Jenner CD Marsden 1991 Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats Brain Res 562 301 305 10.1016/0006-8993(91)90635-9 1:CAS:528:DyaK3MXmslWgt7Y%3D 1685345
42. H Tanaka K Kannari T Maeda M Tomiyama T Suda M Matsunaga 1999 Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats Neuroreport 10 631 634 10.1097/00001756-199902250-00034 1:CAS:528:DyaK1MXisFantL0%3D 10208602
43. LA Wade R Katzman 1975 Rats brain regional uptake and decarboxylation of L-DOPA following carotid injection Am J Physiol 228 352 359 1:CAS:528: DyaE2MXhtFyksbY%3D 1119556
44. H Yamada Y Aimi I Nagatsu K Taki M Kudo R Arai 2007 Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats Neurosci Res 59 1 7 10.1016/j.neures.2007.05.002 1:CAS:528:DC%2BD2sXpsFOjsrY%3D 17586078